Scarica l'app Stockscreener
31.83
1.82%
0.57
Dopo l'orario di chiusura:
31.83
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
CX Institutional Increases Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Capital Management Corp VA Sells 41,191 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
HRMY stock on track for best intraday gains in 18 months — what did Mizuho analysts say? - MSN
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Earnings Preview: HRMY to Report Financial Results Pre-market on May 07 - Moomoo
M3Sixty Small Cap Growth Fund's Harmony Biosciences Holdings Inc(HRMY) Holding History - GuruFocus
Harmony Bio spikes after new Wakix patent litigation - MSN
Harmony Biosciences (HRMY) Projected to Post Quarterly Earnings on Thursday - MarketBeat
A Look At Harmony Biosciences (HRMY) Valuation After CFO Appointment And Reaffirmed 2026 Revenue Outlook - Sahm
Top 5 US Stocks To Buy In May 2026 - Investing.com
Q3 Earnings Estimate for HRMY Issued By HC Wainwright - MarketBeat
Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook - MyChesCo
Assessing Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum And Pipeline Expectations - Yahoo Finance
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook - Investing.com Australia
Research Analysts Issue Forecasts for HRMY Q1 Earnings - MarketBeat
Why Harmony Biosciences (HRMY) Reaffirmed 2026 Revenue Guidance and Hired a Markets-Focused CFO - Yahoo Finance
Harmony Biosciences (HRMY) Attracts Buy Rating Amid IP Litigatio - GuruFocus
Harmony Bio granted FDA label expansion for Wakix in children with narcolepsy - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Press Release: Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Guardant Health (GH), Crescent Biopharma (CBIO) - The Globe and Mail
Ruffer LLP Purchases Shares of 40,993 Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Legend Biotech (LEGN) moves 18.4% higher: Will this strength last? - MSN
Oppenheimer raises Harmony Biosciences stock price target on patent strength - Investing.com
Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed? - simplywall.st
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $72 at Oppenheimer - StreetInsider
HRMY.O - Reuters
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Harmony Biosciences (HRMY) Shares Rise on Positive Patent Litiga - GuruFocus
HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - Stocktwits
Harmony Biosciences (HRMY) Secures Patent Lawsuit Against Generi - GuruFocus
Harmony (HRMY) Sees 14% Surge Following Patent Lawsuit Discovery - GuruFocus
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):